In addition, analysis of the RNA-seq data generated from The Cancer Genome Atlas (TCGA) project revealed high expression of several RhoGAP genes, which are the upstream negative regulators of RhoA, in basal-like breast cancer tumors raising the possibility that RhoGAPs are oncogenic14. This evidence concerns the gene ARHGAP1 and breast carcinoma.